Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2001 1
2007 1
2008 1
2009 2
2010 1
2011 3
2012 2
2013 2
2014 1
2015 7
2016 8
2017 5
2018 5
2019 3
2020 3
2021 3
2022 5
2023 3
2024 9
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for roger af
Search for Rotger AF instead (1 results)
Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury.
Turgeon AF, Fergusson DA, Clayton L, Patton MP, Neveu X, Walsh TS, Docherty A, Malbouisson LM, Pili-Floury S, English SW, Zarychanski R, Moore L, Bonaventure PL, Laroche V, Verret M, Scales DC, Adhikari NKJ, Greenbaum J, Kramer A, Rey VG, Ball I, Khwaja K, Wise M, Harvey D, Lamontagne F, Chabanne R, Algird A, Krueper S, Pottecher J, Zeiler F, Rhodes J, Rigamonti A, Burns KEA, Marshall J, Griesdale DE, Sisconetto LS, Kutsogiannis DJ, Roger C, Green R, Boyd JG, Wright J, Charbonney E, Nair P, Astles T, Sy E, Hébert PC, Chassé M, Gomez A, Ramsay T, Taljaard M, Fox-Robichaud A, Tinmouth A, St-Onge M, Costerousse O, Lauzier F; HEMOTION Trial Investigators on behalf of the Canadian Critical Care Trials Group, the Canadian Perioperative Anesthesia Clinical Trials Group, and the Canadian Traumatic Brain Injury Research Consortium. Turgeon AF, et al. N Engl J Med. 2024 Aug 22;391(8):722-735. doi: 10.1056/NEJMoa2404360. Epub 2024 Jun 13. N Engl J Med. 2024. PMID: 38869931 Clinical Trial.
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE 3rd, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AF; ADAPTABLE Team. Jones WS, et al. N Engl J Med. 2021 May 27;384(21):1981-1990. doi: 10.1056/NEJMoa2102137. Epub 2021 May 15. N Engl J Med. 2021. PMID: 33999548 Free PMC article. Clinical Trial.
Ultrarare heterozygous pathogenic variants of genes causing dominant forms of early-onset deafness underlie severe presbycusis.
Boucher S, Tai FWJ, Delmaghani S, Lelli A, Singh-Estivalet A, Dupont T, Niasme-Grare M, Michel V, Wolff N, Bahloul A, Bouyacoub Y, Bouccara D, Fraysse B, Deguine O, Collet L, Thai-Van H, Ionescu E, Kemeny JL, Giraudet F, Lavieille JP, Devèze A, Roudevitch-Pujol AL, Vincent C, Renard C, Franco-Vidal V, Thibult-Apt C, Darrouzet V, Bizaguet E, Coez A, Aschard H, Michalski N, Lefevre GM, Aubois A, Avan P, Bonnet C, Petit C. Boucher S, et al. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31278-31289. doi: 10.1073/pnas.2010782117. Epub 2020 Nov 23. Proc Natl Acad Sci U S A. 2020. PMID: 33229591 Free PMC article.
We focused on severe presbycusis without environmental or comorbidity risk factors and studied multiplex family age-related hearing loss (mARHL) and simplex/sporadic age-related hearing loss (sARHL) cases and controls with normal hearing by whole-exome sequencing. Ultrarare varia …
We focused on severe presbycusis without environmental or comorbidity risk factors and studied multiplex family age-related hearing loss (mA …
Advanced laceration management.
Brown DJ, Jaffe JE, Henson JK. Brown DJ, et al. Emerg Med Clin North Am. 2007 Feb;25(1):83-99. doi: 10.1016/j.emc.2006.11.001. Emerg Med Clin North Am. 2007. PMID: 17400074 Review.
Emergency medicine considerations in atrial fibrillation.
Long B, Robertson J, Koyfman A, Maliel K, Warix JR. Long B, et al. Am J Emerg Med. 2018 Jun;36(6):1070-1078. doi: 10.1016/j.ajem.2018.01.066. Epub 2018 Feb 1. Am J Emerg Med. 2018. PMID: 29395765 Review.
BACKGROUND: Atrial fibrillation (AF) is an abnormal heart rhythm which may lead to stroke, heart failure, and death. Emergency physicians play a role in diagnosing AF, managing symptoms, and lessening complications from this dysrhythmia. ...This review discusses ED …
BACKGROUND: Atrial fibrillation (AF) is an abnormal heart rhythm which may lead to stroke, heart failure, and death. Emergency physic …
The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
Mehdizadeh M, Naud P, Abu-Taha IH, Hiram R, Xiong F, Xiao J, Saljic A, Kamler M, Vuong-Robillard N, Thorin E, Ferbeyre G, Tardif JC, Sirois MG, Tanguay JF, Dobrev D, Nattel S. Mehdizadeh M, et al. Cardiovasc Res. 2024 Apr 30;120(5):506-518. doi: 10.1093/cvr/cvae003. Cardiovasc Res. 2024. PMID: 38181429 Free PMC article.
AIMS: Cellular senescence is a stress-related or aging response believed to contribute to many cardiac conditions; however, its role in atrial fibrillation (AF) is unknown. Age is the single most important determinant of the risk of AF. The present study was designe …
AIMS: Cellular senescence is a stress-related or aging response believed to contribute to many cardiac conditions; however, its role in atri …
Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension.
Krychtiuk KA, Lopes RD, Cargill VA, Chen R, Cowie MR, Cushman WC, Elkind MSV, Epstein S, Garg PP, Gersh BJ, Giakoumis M, Green JB, Guo W, Kirtane AJ, Lefkowitz M, Lesogor A, Mensah GA, O'Donoghue ML, Ohman EM, Pagidipati NJ, Reboussin D, Roessig L, Roger VL, Sanchez E, Stockbridge N, Touyz RM, Van Spall HGC, Weber MA, Whelton SP, Hernandez AF, Yancy CW, Granger CB. Krychtiuk KA, et al. Hypertension. 2025 Oct;82(10):1599-1611. doi: 10.1161/HYPERTENSIONAHA.125.24992. Epub 2025 Aug 26. Hypertension. 2025. PMID: 40874957 Review.
Evidence and Consensus Based Imaging Guidelines in Multiple Evanescent White Dot Syndrome Multimodal imaging in Uveitis (MUV) Taskforce Report 6.
Munk MR, Stillenmunkes R, Tillmann A, Jampol LM, Cicinelli MV, Lin P, Pepple KL, Freund KB, Tugal-Tutkun I, Habot-Wilner Z, Agarwal A, Gangaputra S, Agrawal R, Jabs DA, Sadda S, Sarraf D, Gupta V; Multimodal Imaging in Uveitis (MUV) Taskforce. Munk MR, et al. Am J Ophthalmol. 2025 Oct;278:191-202. doi: 10.1016/j.ajo.2025.06.039. Epub 2025 Jun 24. Am J Ophthalmol. 2025. PMID: 40571046 Free article.
Global Perspectives on Returning Genetic Research Results in Parkinson Disease.
Tan AH, Saffie-Awad P, Schumacher Schuh AF, Lim SY, Madoev H, Ahmad-Annuar A, Solle J, Wegel CE, Doquenia ML, Dey S, Perinan MT, Makarious MB, Fiske B, Morris HR, Noyce AJ, Alcalay RN, Kumar KR, Klein C; Global Parkinson's Genetic Program (GP2). Tan AH, et al. Neurol Genet. 2024 Dec 5;10(6):e200213. doi: 10.1212/NXG.0000000000200213. eCollection 2024 Dec. Neurol Genet. 2024. PMID: 39807215 Free PMC article.
72 results